News – CMS

2026-08-11

Secretary of the CPC Hainan Provincial Committee Feng Fei Visits Dermavon Hainan

On August 10, 2026, Mr. Feng Fei, Secretary of the Hainan Provincial Committee of the Communist Party of China (CPC), headed a delegation for an inspection tour of Dermavon Hainan, a skin health subsidiary of China Medical System. The delegation conducted an on-site review of the company’s development, innovative R&D, and construction progress of Hainan R&D and Manufacturing Base. The inspection tour was accompanied by Fan Shaojun, Member of the Standing Committee of the Hainan Provincial Committee and Secretary of the Haikou Municipal Committee; Zhang Yong, Mayor of Haikou; Yang Zhongcheng, Director-general of the Policy Research Office of the Hainan Provincial Committee; Qi Shuli, Director of the Hainan Development and Reform Commission; Ji Tiejun, Director of the Hainan Medical Products Administration; Wang Yuan, Deputy Director-General of the Hainan Provincial Department of Industry and Information Technology. During the inspection, Huang Anjun, Executive Director and CEO of Dermavon, gave a briefing to Secretary Feng and the accompanying delegation on the Company’s […]

Learn More

2026-07-27

CMS: Rxilient Obtained Commercialization Rights for Dermatology Improved New Drug Finjuve and Branded Drug Ciclopoli in Southeast Asia and Other Markets

Finjuve, animproved new drug, is the first and only topical finasteride product worldwide approved for the treatment of androgenetic alopecia. Its efficacy is comparable to oral finasteride, while showing 100-fold lower systemic exposure and less impact on serum DHT levels compared with oral finasteride, offering an effective hair-loss treatment option with lower risk. Ciclopoli, a branded drug, uses patented HPCH water-soluble transungual technology. It does not require nail filing or organic solvents to remove the film, combining strong efficacy, safety, and convenience, and offering a superior topical treatment option for onychomycosis patients. Leveraging itsestablished registration and commercialization capabilities across Southeast Asia, Rxilient will accelerate the launch of both products, injecting new momentum into business growth in the region. Recently, the Southeast Asia business subsidiary of China Medical System (“CMS”), Rxilient Medical Pte. Ltd. (“Rxilient”), entered into a partnership with Polichem S.A., a subsidiary of Almirall S.A. (ALM), a global biopharmaceutical company focused on medical dermatology. Rxilient obtained […]

Learn More

2026-07-17

Dual ESG Recognition: CMS Named Among “China ESG Leaders 2026” and Honored with the “Green Supply Chain Leadership Award”

Recently, SynTao Green Finance officially released the Steady Progress for a Sustainable Future: China ESG Leaders Annual Report 2026. China Medical System Holdings Limited (“CMS” or “the Group”) was successfully named among “China ESG Leaders 2026”, recognized for its long-term dedication and outstanding practices in the Environmental, Social, and Governance (ESG) fields. Additionally, CMS was honored with the “Green Supply Chain Leadership Award” in the ESG selection hosted by Stockstar. This double recognition underscores the strong affirmation from professional institutions and the market for the Group’s sustainable development initiatives. Published by SynTao Green Finance, a leading ESG rating agency in China, the Steady Progress for a Sustainable Future: China ESG Leaders Annual Report 2026 is widely recognized for its high credibility and influence. Stockstar’s “ESG New Benchmark Awards”, themed “Innovation, Co-governance, Long-term Value”, introduced the “Green Supply Chain Leadership Award” for the first time. The award specifically focuses on corporate practices and achievements in building green, low-carbon, and responsible supply chains. As […]

Learn More

Company News

Latest News

Secretary of the CPC Hainan Provincial Committee Feng Fei Visits Dermavon Hainan

CMS: Rxilient Obtained Commercialization Rights for Dermatology Improved New Drug Finjuve and Branded Drug Ciclopoli in Southeast Asia and Other Markets

Dual ESG Recognition: CMS Named Among “China ESG Leaders 2026” and Honored with the “Green Supply Chain Leadership Award”

All News